Flavonoids activate wild-type p53

被引:0
|
作者
Plaumann, B
Fritsche, M
Rimpler, H
Brandner, G
Hess, RD
机构
[1] UNIV FREIBURG, INST MED MIKROBIOL & HYG, ABT VIROL, D-79104 FREIBURG, GERMANY
[2] INST EXPT KREBSFORSCH, KLIN TUMORBIOL, D-79106 FREIBURG, GERMANY
[3] UNIV FREIBURG, INST PHARMAZEUT BIOL, D-79104 FREIBURG, GERMANY
关键词
flavonoids; p53; cell cycle; G2M; apoptosis; DNA damage;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Flavonoids are diphenyl propanoids widely distributed in edible plants. They play a dual role in mutagenesis and carcinogenesis. Some of them act as anticarcinogens or inhibit the growth of tumour cells, whereas others act as cocarcinogens, are mutagenic or able to induce DNA damage. To further elucidate this dual role, we investigated the influence of apigenin, luteolin and quercetin on the tumour suppressor protein p53, regarding p53 accumulation, cell cycle arrest, apoptosis, and biological activity. We found that incubation of the non-tumour cell line C3H10T1/2CL8 with these flavonoids resulted in induction of p53 accumulation and apoptosis. Apoptosis occurred out of the G(2)/M phase of the cell cycle, The G(2)/M arrest seems to be p53-dependent as it did not occur in p53 knockout fibroblasts which further supports the recent finding that p53 is involved in the G(2)/M checkpoint control. Differences between the flavonoids tested concerned p53 accumulation kinetics as well as the biological activity of accumulated p53 and might be due to different modes of flavonoid action. These data suggest that both aspects of flavonoid effects, i.e. inhibition of tumour growth through cell cycle arrest and induction of apoptosis, are functionally related to p53.
引用
收藏
页码:1605 / 1614
页数:10
相关论文
共 50 条
  • [41] Germ cell tumors of the testis overexpress wild-type p53
    Guillou, L
    Estreicher, A
    Chaubert, P
    Hurlimann, J
    Kurt, AM
    Metthez, G
    Iggo, R
    Gray, AC
    Jichlinski, P
    Benhattar, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (04): : 1221 - 1228
  • [42] TEMPERATURE SENSITIVITY FOR CONFORMATION IS AN INTRINSIC PROPERTY OF WILD-TYPE P53
    HAINAUT, P
    BUTCHER, S
    MILNER, J
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 227 - 231
  • [43] Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma
    Becker, K.
    Marchenko, N. D.
    Maurice, M.
    Moll, U. M.
    [J]. CELL DEATH AND DIFFERENTIATION, 2007, 14 (07): : 1350 - 1360
  • [44] Increased epidermal functioning wild-type p53 expression in vitiligo
    Schallreuter, KU
    Behrens-Williams, S
    Khaliq, TP
    Picksley, SM
    Peters, EMJ
    Marles, LK
    Westerhof, W
    Miehe, B
    Fanghänel, J
    [J]. EXPERIMENTAL DERMATOLOGY, 2003, 12 (03) : 268 - 277
  • [45] Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins
    Moos, PJ
    Edes, K
    Fitzpatrick, FA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) : 9215 - 9220
  • [46] INHIBITION OF VIRAL AND CELLULAR PROMOTERS BY HUMAN WILD-TYPE P53
    SUBLER, MA
    MARTIN, DW
    DEB, S
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (08) : 4757 - 4762
  • [47] Prolonged wild-type p53 protein accumulation and cisplatin resistance
    Yazlovitskaya, EM
    DeHaan, RD
    Persons, DL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (04) : 732 - 737
  • [48] Wild-type and mutant forms of p53 activate human topoisomerase I: A possible mechanism for gain of function in mutants
    Albor, A
    Kaku, S
    Kulesz-Martin, M
    [J]. CANCER RESEARCH, 1998, 58 (10) : 2091 - 2094
  • [49] TRANSCRIPTIONAL ACTIVATION BY WILD-TYPE BUT NOT TRANSFORMING MUTANTS OF THE P53 ANTIONCOGENE
    RAYCROFT, L
    WU, H
    LOZANO, G
    [J]. SCIENCE, 1990, 249 (4972) : 1049 - 1051
  • [50] NEGATIVE FEEDBACK-REGULATION OF WILD-TYPE P53 BIOSYNTHESIS
    MOSNER, J
    MUMMENBRAUER, T
    BAUER, C
    SCZAKIEL, G
    GROSSE, F
    DEPPERT, W
    [J]. EMBO JOURNAL, 1995, 14 (18): : 4442 - 4449